Many studies have related S100B to a diversity of psychiatric and neurodegenerative diseases, such as Alzheimer’s disease, Down’s syndrome, schizophrenia, and Tourette’s syndrome, in addition to the known correlation between S100B and trauma and stroke. Here, S100B is linked to early-onset autosomal dominant Alzheimer disease.